BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perdomo CM, Frühbeck G, Escalada J. Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. Nutrients 2019;11:E677. [PMID: 30901929 DOI: 10.3390/nu11030677] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Hwangbo H, Kim MY, Ji SY, Kim SY, Lee H, Kim GY, Park C, Keum YS, Hong SH, Cheong J, Choi YH. Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro. Antioxidants (Basel) 2020;9:E1040. [PMID: 33114221 DOI: 10.3390/antiox9111040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Behl T, Kaur I, Sehgal A, Singh S, Zengin G, Negrut N, Nistor-Cseppento DC, Pavel FM, Corb Aron RA, Bungau S. Exploring the Genetic Conception of Obesity via the Dual Role of FoxO. Int J Mol Sci 2021;22:3179. [PMID: 33804729 DOI: 10.3390/ijms22063179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Deng Z, Gao S, An Y, Huang Y, Liu H, Zhu W, Lu W, He M, Xie W, Yu D, Li Y. Effects of earthworm extract on the lipid profile and fatty liver induced by a high-fat diet in guinea pigs. Ann Transl Med 2021;9:292. [PMID: 33708919 DOI: 10.21037/atm-20-5362] [Reference Citation Analysis]
4 Monserrat-mesquida M, Quetglas-llabrés M, Bouzas C, Montemayor S, Mascaró CM, Casares M, Llompart I, Gámez JM, Tejada S, Martínez JA, Tur JA, Sureda A. A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease. Antioxidants 2022;11:1266. [DOI: 10.3390/antiox11071266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Adeyanju OA, Badejogbin OC, Areola DE, Olaniyi KS, Dibia C, Soetan OA, Oniyide AA, Michael OS, Olatunji LA, Soladoye AO. Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats. Biomed Pharmacother 2021;133:110994. [PMID: 33197764 DOI: 10.1016/j.biopha.2020.110994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Amanatidou AI, Kaliora AC, Amerikanou C, Stojanoski S, Milosevic N, Vezou C, Beribaka M, Banerjee R, Kalafati IP, Smyrnioudis I, Kurth MJ, Kannt A, Francino MP, Visvikis-Siest S, Deloukas P, Llorens C, Marascio F, Milic N, Medic-Stojanoska M, Gastaldelli A, Trivella MG, Dedoussis GV. Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study. Int J Environ Res Public Health 2022;19:971. [PMID: 35055797 DOI: 10.3390/ijerph19020971] [Reference Citation Analysis]
7 Namkhah Z, Naeini F, Ostadrahimi A, Tutunchi H, Hosseinzadeh-Attar MJ. The association of the adipokine zinc-alpha2-glycoprotein with non-alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. Int J Clin Pract 2021;75:e13985. [PMID: 33404166 DOI: 10.1111/ijcp.13985] [Reference Citation Analysis]
8 Ahadi M, Molooghi K, Masoudifar N, Namdar AB, Vossoughinia H, Farzanehfar M. A review of non-alcoholic fatty liver disease in non-obese and lean individuals. J Gastroenterol Hepatol 2021;36:1497-507. [PMID: 33217052 DOI: 10.1111/jgh.15353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ebrahimi Mousavi S, Dehghanseresht N, Dashti F, Khazaei Y, Salamat S, Asbaghi O, Mansoori A. The association between Dietary Diversity Score and odds of nonalcoholic fatty liver disease: a case-control study. Eur J Gastroenterol Hepatol 2022;34:678-85. [PMID: 35352692 DOI: 10.1097/MEG.0000000000002344] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee JH, Zhu J. Analyses of short-chain fatty acids and exhaled breath volatiles in dietary intervention trials for metabolic diseases. Exp Biol Med (Maywood) 2021;246:778-89. [PMID: 33327781 DOI: 10.1177/1535370220979952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Berná G, Romero‐gomez M. The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management. Liver Int 2020;40:102-8. [DOI: 10.1111/liv.14360] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
12 Ghosh A, Dutta K, Bhatt SP, Gupta R, Tyagi K, Ansari IA, Venugopal VK, Mahajan H, Pandey RM, Pandey S, Misra A. Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India. J Clin Endocrinol Metab 2022;107:e2267-75. [PMID: 35263436 DOI: 10.1210/clinem/dgac138] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Monserrat-Mesquida M, Quetglas-Llabrés M, Abbate M, Montemayor S, Mascaró CM, Casares M, Tejada S, Abete I, Zulet MA, Tur JA, Martínez JA, Sureda A. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants (Basel) 2020;9:E759. [PMID: 32824349 DOI: 10.3390/antiox9080759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Shen C, Chen JH, Oh HR, Park JH. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36. FEBS Lett 2021;595:2493-503. [PMID: 34536973 DOI: 10.1002/1873-3468.14193] [Reference Citation Analysis]
15 Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Hosseinzadeh-Attar MJ, Shakeri A, Asghari-Jafarabadi M, Roshanravan N, Farrin N, Naemi M, Hasankhani M. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes. Pharmacol Res 2020;156:104770. [PMID: 32217148 DOI: 10.1016/j.phrs.2020.104770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
16 Zhou J, Tripathi M, Sinha RA, Singh BK, Yen PM. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease. Hepatoma Res 2021;7:11. [PMID: 33490737 DOI: 10.20517/2394-5079.2020.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Policarpo S, Machado M, Barreira D, Cortez-pinto H. NAFLD Nutritional Management: Results from a Multidisciplinary Approach. GE Port J Gastroenterol. [DOI: 10.1159/000519932] [Reference Citation Analysis]
18 Della Torre S. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne) 2020;11:572490. [PMID: 33071979 DOI: 10.3389/fendo.2020.572490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
19 Recaredo G, Marin-Alejandre BA, Cantero I, Monreal JI, Herrero JI, Benito-Boillos A, Elorz M, Tur JA, Martínez JA, Zulet MA, Abete I. Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study. Nutrients 2019;11:E2359. [PMID: 31623368 DOI: 10.3390/nu11102359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
20 Rahmadi M, Nurhan AD, Pratiwi ED, Prameswari DA, Panggono SM, Nisak K, Khotib J. The effect of various high-fat diet on liver histology in the development of NAFLD models in mice. J Basic Clin Physiol Pharmacol 2021;32:547-53. [PMID: 34214382 DOI: 10.1515/jbcpp-2020-0426] [Reference Citation Analysis]
21 Farhangi MA, Dehghan P, Musazadeh V, Kavyani M, Maleki P. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Journal of Functional Foods 2022;92:105074. [DOI: 10.1016/j.jff.2022.105074] [Reference Citation Analysis]
22 Golonka RM, Xiao X, Abokor AA, Joe B, Vijay-Kumar M. Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota. J Nutr Biochem 2020;80:108360. [PMID: 32163821 DOI: 10.1016/j.jnutbio.2020.108360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
23 Asghari S, Rezaei M, Rafraf M, Taghizadeh M, Asghari-Jafarabadi M, Ebadi M. Effects of Calorie Restricted Diet on Oxidative/Antioxidative Status Biomarkers and Serum Fibroblast Growth Factor 21 Levels in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Controlled Clinical Trial. Nutrients 2022;14:2509. [PMID: 35745238 DOI: 10.3390/nu14122509] [Reference Citation Analysis]
24 Song C, Lv W, Li Y, Nie P, Lu J, Geng Y, Heng Z, Song L. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats. Nutr Metab (Lond) 2021;18:106. [PMID: 34922572 DOI: 10.1186/s12986-021-00631-7] [Reference Citation Analysis]
25 Gillespie J. "You Are What You Eat": The Role of Dietary Macronutrients and Micronutrients in MAFLD. Clin Liver Dis (Hoboken) 2021;18:67-71. [PMID: 34584670 DOI: 10.1002/cld.1083] [Reference Citation Analysis]
26 Sandner G, König A, Wallner M, Weghuber J. Functional foods - dietary or herbal products on obesity: application of selected bioactive compounds to target lipid metabolism. Current Opinion in Food Science 2020;34:9-20. [DOI: 10.1016/j.cofs.2020.09.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Policarpo S, Carvalhana S, Craciun A, Crespo RR, Cortez-Pinto H. Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake? Nutrients 2022;14:1335. [PMID: 35405948 DOI: 10.3390/nu14071335] [Reference Citation Analysis]
28 Jarmakiewicz-czaja S, Sokal A, Pardak P, Filip R, Granito A. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-13. [DOI: 10.1155/2022/4344905] [Reference Citation Analysis]
29 Qi Y, Fan L, Ran D, Xu J, Wang Y, Wu J, Zhang Z. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Oncol 2021;2021:7764817. [PMID: 34691178 DOI: 10.1155/2021/7764817] [Reference Citation Analysis]
30 Musazadeh V, Roshanravan N, Dehghan P, Ahrabi SS. Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis. Front Nutr 2022;9:844242. [DOI: 10.3389/fnut.2022.844242] [Reference Citation Analysis]
31 Pafili K, Roden M. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab 2021;50:101122. [PMID: 33220492 DOI: 10.1016/j.molmet.2020.101122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Harder NHO, Lee HP, Flood VJ, San Juan JA, Gillette SK, Heffern MC. Fatty Acid Uptake in Liver Hepatocytes Induces Relocalization and Sequestration of Intracellular Copper. Front Mol Biosci 2022;9:863296. [DOI: 10.3389/fmolb.2022.863296] [Reference Citation Analysis]
33 Pacifico L, Perla FM, Chiesa C. Impact of healthy plant-based diet on abdominal visceral and liver fat contents. Hepatobiliary Surg Nutr 2021;10:136-8. [PMID: 33575306 DOI: 10.21037/hbsn-20-760] [Reference Citation Analysis]
34 Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Roshanravan N, Shakeri-Bavil A, Asghari-Jafarabadi M, Farrin N, Mobasseri M. Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial. J Cell Physiol 2021;236:417-26. [PMID: 32572955 DOI: 10.1002/jcp.29870] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Moussa I, Day RS, Li R, Kaseb A, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med 2021;10:7308-19. [PMID: 34535983 DOI: 10.1002/cam4.4256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Rezzani R, Franco C. Liver, Oxidative Stress and Metabolic Syndromes. Nutrients 2021;13:301. [PMID: 33494242 DOI: 10.3390/nu13020301] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Pérez-Montes de Oca A, Julián MT, Ramos A, Puig-Domingo M, Alonso N. Microbiota, Fiber, and NAFLD: Is There Any Connection? Nutrients 2020;12:E3100. [PMID: 33053631 DOI: 10.3390/nu12103100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Namkhah Z, Naeini F, Mahdi Rezayat S, Mehdi Yaseri, Mansouri S, Javad Hosseinzadeh-Attar M. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial. Int J Clin Pract 2021;75:e14852. [PMID: 34516703 DOI: 10.1111/ijcp.14852] [Reference Citation Analysis]
39 Luu HN, Neelakantan N, Geng TT, Wang R, Goh GB, Clemente JC, Jin A, van Dam RM, Jia W, Behari J, Koh WP, Yuan JM. Quality diet indexes and risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study. Int J Cancer 2021;148:2102-14. [PMID: 33129230 DOI: 10.1002/ijc.33367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Moszak M, Szulińska M, Walczak-Gałęzewska M, Bogdański P. Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date. Int J Environ Res Public Health 2021;18:1616. [PMID: 33567710 DOI: 10.3390/ijerph18041616] [Reference Citation Analysis]
41 Mohammadzadeh G, Afarin R, Bavarsad SS, Aslani F, Zadeh SA, Shakerian E. Comparison of the effects of cholesterol, palmitic acid, and glucose on activation of human hepatic stellate cells to induce liver fibrosis. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01095-z] [Reference Citation Analysis]
42 Yang H, Arif M, Yuan M, Li X, Shong K, Türkez H, Nielsen J, Uhlén M, Borén J, Zhang C, Mardinoglu A. A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease. iScience 2021;24:103222. [PMID: 34712920 DOI: 10.1016/j.isci.2021.103222] [Reference Citation Analysis]
43 Gual P. Pharmacological treatments of the "Fibrotic-NASH": Towards a delivery on time? Clin Res Hepatol Gastroenterol 2019;43:623-4. [PMID: 31300372 DOI: 10.1016/j.clinre.2019.06.013] [Reference Citation Analysis]
44 Vancells Lujan P, Viñas Esmel E, Sacanella Meseguer E. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. Nutrients 2021;13:1442. [PMID: 33923255 DOI: 10.3390/nu13051442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Lim HS, Choi J, Lee B, Kim SG, Kim YS, Yoo JJ. Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. Clin Nutr Res 2020;9:182-94. [PMID: 32789148 DOI: 10.7762/cnr.2020.9.3.182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Naeini F, Namkhah Z, Ostadrahimi A, Tutunchi H, Hosseinzadeh-Attar MJ. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Adv Nutr 2021;12:413-28. [PMID: 32879962 DOI: 10.1093/advances/nmaa106] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
47 Hajdarevic B, Vehabovic I, Catic T, Masic I. The Role of Diet Therapy in the Treatment of Liver Disease. Mater Sociomed 2020;32:200-6. [PMID: 33424449 DOI: 10.5455/msm.2020.32.196-199] [Reference Citation Analysis]
48 Crosby L, Davis B, Joshi S, Jardine M, Paul J, Neola M, Barnard ND. Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks. Front Nutr 2021;8:702802. [PMID: 34336911 DOI: 10.3389/fnut.2021.702802] [Reference Citation Analysis]
49 Wang J, Zhang Y, Zhou M, Zheng M, Cui J, Liu Z, Liu C, Liu S. Rapid screening and evaluation of XOD inhibitors and O 2•− scavenger from total flavonoids of Ginkgo biloba leaves by LC–MS and multimode microplate reader. Biomedical Chromatography 2020;34. [DOI: 10.1002/bmc.4852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Ziolkowska S, Binienda A, Jabłkowski M, Szemraj J, Czarny P. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:11128. [PMID: 34681787 DOI: 10.3390/ijms222011128] [Reference Citation Analysis]
51 Ramos LF, Silva CM, Pansa CC, Moraes KCM. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Rev Gastroenterol Hepatol 2021;15:25-40. [PMID: 32892668 DOI: 10.1080/17474124.2020.1820321] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Tutunchi H, Saghafi-Asl M, Asghari-Jafarabadi M, Ostadrahimi A. The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults. BMC Res Notes 2020;13:218. [PMID: 32299490 DOI: 10.1186/s13104-020-05059-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
53 Panyod S, Sheen LY. Beneficial effects of Chinese herbs in the treatment of fatty liver diseases. J Tradit Complement Med 2020;10:260-7. [PMID: 32670821 DOI: 10.1016/j.jtcme.2020.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Sohouli MH, Sayyari AA, Lari A, Nameni G, Lotfi M, Fatahi S, Saneie S, Găman MA, Moodi F, Raee P, Aghamiri S, Rayi A, Shahriari A, Moodi V. Association of dietary insulinaemic potential and odds of non-alcoholic fatty liver disease among adults: A case-control study. J Hum Nutr Diet 2021;34:901-9. [PMID: 33586811 DOI: 10.1111/jhn.12865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Perdomo CM, Garcia-Fernandez N, Escalada J. Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate? J Clin Med 2021;10:2040. [PMID: 34068699 DOI: 10.3390/jcm10092040] [Reference Citation Analysis]
56 Naeini F, Namkhah Z, Tutunchi H, Rezayat SM, Mansouri S, Jazayeri-Tehrani SA, Yaseri M, Hosseinzadeh-Attar MJ. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial. Trials 2021;22:801. [PMID: 34774104 DOI: 10.1186/s13063-021-05784-7] [Reference Citation Analysis]
57 Behl T, Kaur I, Sehgal A, Singh S, Zengin G, Negrut N, Nistor-cseppento DC, Pavel FM, Corb Aron RA, Bungau S. Exploring the Genetic Conception of Obesity via the Dual Role of FoxO. IJMS 2021;22:3179. [DOI: 10.3390/ijms22063179] [Reference Citation Analysis]
58 Zhang Y, Liu Z, Choudhury T, Cornelis MC, Liu W. Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study. Eur J Nutr 2021;60:1761-7. [PMID: 32856188 DOI: 10.1007/s00394-020-02369-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Hoang T. An approach of fatty acids and resveratrol in the prevention of COVID-19 severity. Phytother Res 2020. [PMID: 33200839 DOI: 10.1002/ptr.6956] [Reference Citation Analysis]
60 Kwak JH, Lee HJ, Jeong ST, Lee JY, Lee M, Paik JK. Effect of fermented Rhus verniciflua stokes extract on liver function parameters in healthy Korean adults: a double-blind randomized controlled trial. Trials 2021;22:830. [PMID: 34809689 DOI: 10.1186/s13063-021-05656-0] [Reference Citation Analysis]
61 Park SY, Noureddin M, Boushey C, Wilkens LR, Setiawan VW. Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort. Curr Dev Nutr 2020;4:nzaa024. [PMID: 32190810 DOI: 10.1093/cdn/nzaa024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
62 Marin-alejandre BA, Abete I, Monreal JI, Elorz M, Benito-boillos A, Herrero JI, Navarro-blasco I, Tur JA, Bandarra NM, Zulet MA, Martinez JA. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study. Journal of Clinical Lipidology 2020;14:837-849.e2. [DOI: 10.1016/j.jacl.2020.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Della Torre S. Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells 2021;10:2502. [PMID: 34572151 DOI: 10.3390/cells10092502] [Reference Citation Analysis]
64 Raza S, Tewari A, Rajak S, Sinha RA. Vitamins and non-alcoholic fatty liver disease: A Molecular Insight. Liver Res 2021;5:62-71. [PMID: 34221537 DOI: 10.1016/j.livres.2021.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Coronati M, Baratta F, Pastori D, Ferro D, Angelico F, Del Ben M. Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review. Nutrients 2022;14:1127. [PMID: 35334784 DOI: 10.3390/nu14061127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]